62 related articles for article (PubMed ID: 2699722)
1. [Acceptability of the Hemoccult test in general medical practice. Results of a pilot study].
Archambault F; Durand G; Faivre J; Voilquin JP; Archambault P; Riou F; Ageorges P; Archambault ML; Delville JM; Fesneau M
Bull Cancer; 1989; 76(10):1071-5. PubMed ID: 2699722
[TBL] [Abstract][Full Text] [Related]
2. [Preliminary results of a mass screening program for colorectal cancer].
Bedenne L; Durand G; Faivre J; Milan C; Boutron MC; Arveux P; Colombier P; Klepping C
Gastroenterol Clin Biol; 1990; 14(2):140-5. PubMed ID: 2328881
[TBL] [Abstract][Full Text] [Related]
3. The view from two sides: a qualitative study of community and medical perspectives on screening for colorectal cancer using FOBT.
Clavarino AM; Janda M; Hughes KL; Del Mar C; Tong S; Stanton WR; Aitken JF; Leggett BA; Newman B
Prev Med; 2004 Sep; 39(3):482-90. PubMed ID: 15313087
[TBL] [Abstract][Full Text] [Related]
4. Participation in mass screening for colorectal cancer: results of screening and rescreening from the Burgundy study.
Faivre J; Arveux P; Milan C; Durand G; Lamour J; Bedenne L
Eur J Cancer Prev; 1991 Oct; 1(1):49-55. PubMed ID: 1842684
[TBL] [Abstract][Full Text] [Related]
5. Acceptability and compliance in screening for colorectal cancer with fecal occult blood test.
Adamsen S; Kronborg O
Scand J Gastroenterol; 1984 Jun; 19(4):531-4. PubMed ID: 6463577
[TBL] [Abstract][Full Text] [Related]
6. [Mass screening for colorectal cancer].
Faivre J; Tazi MA; Launoy G
Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S7-14. PubMed ID: 8935859
[TBL] [Abstract][Full Text] [Related]
7. Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network.
Young WF; McGloin J; Zittleman L; West DR; Westfall JM
J Rural Health; 2007; 23(3):238-45. PubMed ID: 17565524
[TBL] [Abstract][Full Text] [Related]
8. Screening for colorectal cancer: a general-practice-based study.
Marjoram J; Strachan R; Allan A; Allan E
Br J Gen Pract; 1996 May; 46(406):283-86. PubMed ID: 8762743
[TBL] [Abstract][Full Text] [Related]
9. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
Levin B; Hess K; Johnson C
Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
[TBL] [Abstract][Full Text] [Related]
10. [Performance of the Hemoccult test in the screening of colorectal cancer and adenoma. Results of 5 screening campaigns in Saône-et-Loire].
Tazi MA; Faivre J; Lejeune C; Benhamiche AM; Dassonville F
Gastroenterol Clin Biol; 1999 May; 23(5):475-80. PubMed ID: 10429850
[TBL] [Abstract][Full Text] [Related]
11. [Cost of a mass screening program for colorectal cancer using the occult blood test].
Arveux P; Faivre J; Bedenne L; Durand G; Milan C; Milan C
Gastroenterol Clin Biol; 1992; 16(6-7):547-51. PubMed ID: 1526416
[TBL] [Abstract][Full Text] [Related]
12. [General practitioners' experience in a mass screening campaign of colorectal cancers].
Durand G; Arveux P; Milan C; Quelier C; Bedenne L; Faivre J
Cah Sociol Demogr Med; 1992; 32(2-3):191-205. PubMed ID: 1297544
[TBL] [Abstract][Full Text] [Related]
13. Population colorectal cancer screening with fecal occult blood test.
Rennert G; Rennert HS; Miron E; Peterburg Y
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1165-8. PubMed ID: 11700264
[TBL] [Abstract][Full Text] [Related]
14. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of a clinic-based support staff intervention to increase the rate of fecal occult blood test ordering.
Thompson NJ; Boyko EJ; Dominitz JA; Belcher DW; Chesebro BB; Stephens LM; Chapko MK
Prev Med; 2000 Mar; 30(3):244-51. PubMed ID: 10684748
[TBL] [Abstract][Full Text] [Related]
17. Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing?
Tong S; Hughes K; Oldenburg B; Del Mar C
Intern Med J; 2004; 34(9-10):532-8. PubMed ID: 15482265
[TBL] [Abstract][Full Text] [Related]
18. Screening for colorectal cancer. Knowledge, attitudes and practices of South Australian GPs.
Weller D; Hiller J; Beilby J; Woodward A
Med J Aust; 1994 May; 160(10):620-4. PubMed ID: 8177107
[TBL] [Abstract][Full Text] [Related]
19. Survey on colorectal cancer screening knowledge, attitudes, and practices of general practice physicians in Lazio, Italy.
Federici A; Giorgi Rossi P; Bartolozzi F; Farchi S; Borgia P; Guasticchi G
Prev Med; 2005 Jul; 41(1):30-5. PubMed ID: 15916990
[TBL] [Abstract][Full Text] [Related]
20. Are there gender differences in colorectal cancer test use prevalence and correlates?
McQueen A; Vernon SW; Meissner HI; Klabunde CN; Rakowski W
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):782-91. PubMed ID: 16614124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
